Forget Daily Pills—Intellia Therapeutics (NTLA) is Creating Cures You Only Need Once
Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a biotechnology company at the forefront of a genomic revolution, pioneering the development…
Nektar Therapeutics (NKTR) Skyrockets 350% in a Week!
Nektar Therapeutics (NASDAQ:NKTR) is a San Francisco-based biotechnology company that has spent over three decades pushing the boundaries…
Soleno Therapeutics (SLNO): The Biotech Company That Could Make You Rich
Soleno Therapeutics Inc. (NASDAQ:SLNO) is an innovative biotechnology company at the forefront of developing treatments for rare diseases…
Investing in Ultragenyx (RARE): The Biotech Stock With 100%+ Upside Potential
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is an innovative biotechnology company that has carved out a prominent position in the…
Exact Sciences (EXAS) Just Made Cancer Detection 100x Easier!
Exact Sciences Corporation (NASDAQ:EXAS) is a pioneering biotechnology company committed to improving the lives of patients through groundbreaking…
BioCryst (BCRX) is a Top Stock for Investors Focused on Rare Diseases
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX), headquartered in Research Triangle Park, North Carolina, is a pioneering biotechnology company committed to…
Can Medtronic (MDT)’s MiniMed Spin-Off Unlock Billions? Wall Street Thinks So
Medtronic plc (NYSE:MDT) stands today as one of the world’s largest and most influential medical technology companies, yet…
Novo Nordisk (NVO)’s New Pill Promises Double-Digit Weight Loss—Could it Blow Up the GLP-1 Market?
Founded in 1923 and headquartered in Bagsværd, Denmark, Novo Nordisk A/S (NYSE:NVO) is a global healthcare company and…
XPro™ Could Be the Holy Grail in Alzheimer’s Treatment — And INmune Bio (INMB) Owns It
INmune Bio Inc. (NASDAQ:INMB)is a clinical-stage biotechnology company pioneering a new frontier in immunotherapy by targeting the innate…
Aurinia Pharmaceuticals (AUPH) Just Turned Profitable — Is This the Most Undervalued Biotech Stock of 2025?
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a late-stage biopharmaceutical company headquartered in Victoria, British Columbia, with U.S. commercial operations…
RAPT Therapeutics (RAPT) Poised for Massive Breakout After Reverse Split and Clinical Wins
RAPT Therapeutics, Inc. (NASDAQ:RAPT) is a clinical-stage biopharmaceutical company at the forefront of precision immunology, developing oral small…
Could Seres Therapeutics (MRCB) Replace Antibiotics? This Biotech’s Next Drug Could Do It
Seres Therapeutics (MRCB), based in Cambridge, Massachusetts, stands at the vanguard of the live biotherapeutics revolution. Since its…
GlucoTrack (GCTK)’s Implant Could Kill Finger-Prick Testing Forever—Investors are Starting to Notice
GlucoTrack Inc. (NASDAQ:GCTK) is a pioneering medical technology company that has spent over two decades innovating diabetes management…
Sarepta Therapeutics (SRPT) May Be the Next $200 Biotech Stock Wall Street is Watching
Founded in 1980 and headquartered in Cambridge, Massachusetts, Sarepta Therapeutics Inc. (NASDAQ:SRPT) is a cutting-edge biotechnology company at…
Wall Street is Turning Bullish on Salarius Pharmaceuticals (SLRX)
Salarius Pharmaceuticals Inc. (NASDAQ:SLRX) is a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for patients suffering from…
Conduit Pharmaceuticals (CDT) Could Deliver Massive Gains
Conduit Pharmaceuticals Inc. (NASDAQ:CDT) is a clinical-stage biopharmaceutical company that is transforming the traditional model of drug development…
Could Lixte Biotechnology (LIXT) Turn a $1 Stock into a Multi-Bagger in 2025?
Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a pioneering clinical-stage pharmaceutical company focused on unlocking new frontiers in oncology…
Alzamend Neuro (ALZN) Could Be the Next 10x Biotech Breakout in 2025
Alzamend Neuro Inc. (NASDAQ:ALZN) is a forward-thinking clinical-stage biopharmaceutical company on a mission to revolutionize the treatment landscape…